USA |NASDAQ |USD
|Public Float||31.01M||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||10.64%||Ex-Dividend Date|
|Held by Institutions||88.87%||IPO Date||Oct 4, 2018|
|Dec 20||Dec 19||Dec 18|
|Sep 21||Jun 21||Mar 21|
|Jan 21, 2022||$59.48||$60.88||$56.19||$57.80||-4.37%||644.40K|
Kodiak sciences is expected to report earnings on May 09 ,2022.
View More Details on Kodiak sciences's 'Earnings' Section
Kodiak sciences trades on the NASDAQ stock market in USA under the ticker symbol "KOD". Kodiak sciences’s stock symbol can also be displayed as "NASDAQ:KOD".
Kodiak sciences (NASDAQ:KOD) is owned by 88.87% institutional shareholders and by 10.64% insiders. The rest is owned by the public.
The 3 top institutional shareholders are "Baker Bros Advisors LP", "T. Rowe Price Associates, Inc." and "Wellington Management Company LLP", representing 55.93% of Kodiak sciences’s total shares outstanding.
Explore More Details on Kodiak sciences's “Ownership” Section
Kodiak sciences's key executive team includes the following managers:
Kodiak sciences (NASDAQ:KOD) is classified under the "Healthcare" sector and under the "Biotechnology" industry.
Currently the number of employees working for Kodiak sciences is 85.
Kodiak sciences (NASDAQ:KOD) is headquartered in CA, United States.
Kodiak sciences’s mailing address is 1200 Page Mill Road, Palo Alto, CA, United States, 94304.
The company’s phone number is 650 281 0850.